Insiders · Profile

Nissenson Allen

Director at Elicio Therapeutics · Chief Medical Officer at DaVita. Filing since 12 Mar 2010. CIK 0001441889

ELTX Elicio Therapeutics, Inc. Director · 2 trades DVA DaVita Chief Medical Officer · 12 trades

Company

Date

Role

Action

Shares

Amount

Of holding

ELTX Elicio Therapeutics, Inc.

20 May 2022

Director

Bought

2,037

$2.40K

27.7%

ELTX Elicio Therapeutics, Inc.

19 May 2022

Director

Bought

7,346

$8.52K

opened

13 Feb 2014

Chief Medical Officer

Sold, plan not stated

2,547

$168.51K

22.1%

17 Dec 2013

Chief Medical Officer

Sold, plan not stated

2,929

$175.24K

53.9%

13 May 2013

Chief Medical Officer

Sold, plan not stated

776

$101.17K

38.2%

6 Mar 2013

Chief Medical Officer

Sold, plan not stated

2,422

$299.78K

65.9%

15 Nov 2012

Chief Medical Officer

Sold, plan not stated

4,110

$462.38K

81.6%

6 Aug 2012

Chief Medical Officer

Sold, plan not stated

3,919

$387.61K

80.9%

23 May 2012

Chief Medical Officer

Sold, plan not stated

6,016

$481.28K

86.7%

17 May 2011

Chief Medical Officer

Sold, plan not stated

2,521

$216.81K

73.2%

25 Feb 2011

Chief Medical Officer

Sold, plan not stated

1,103

$86.59K

54.4%

9 Nov 2010

Chief Medical Officer

Sold, plan not stated

1,820

$131.78K

78.4%

17 Jun 2010

Chief Medical Officer

Sold, plan not stated

191

$12.65K

27.6%

12 Mar 2010

Chief Medical Officer

Sold, plan not stated

4,203

$262.69K

89.4%

14 decisions on file.